During the past decade, University of Hawaii Cancer Center conducted 144 clinical trials. In the 10-year time frame, 144 clinical trials started and 193 clinical trials were completed, i.e. on average, 134% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 98 clinical trials were completed. i.e. 196% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Hawaii Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 134 trials, followed by "SWOG Cancer Research Network" with 110 trials sponsored, "Children's Oncology Group" with 96 trials sponsored, "Alliance for Clinical Trials in Oncology" with 46 trials sponsored and "NSABP Foundation Inc" with 46 trials sponsored. Other sponsors include 99 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Hawaii Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 332 trials as a collaborator, "NRG Oncology" with 36 trials as a collaborator, "SWOG Cancer Research Network" with 23 trials as a collaborator, "Cancer and Leukemia Group B" with 16 trials as a collaborator and "NCIC Clinical Trials Group" with 13 trials as a collaborator. Other collaborators include 98 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "University of Hawaii Cancer Center" are "Breast Cancer" (46 trials), "Leukemia" (31 trials), "Lymphoma" (25 trials), "Lung Cancer" (16 trials) and "Sarcoma" (16 trials). Many other conditions were trialed in "University of Hawaii Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Hawaii Cancer Center" are "Drug" (399 trials), "Other" (227 trials), "Biological" (161 trials), "Procedure" (98 trials) and "Radiation" (84 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (124 trials), "Quality-of-Life Assessment" (63 trials), "cyclophosphamide" (46 trials), "Questionnaire Administration" (45 trials) and "filgrastim" (37 trials). Other intervention names were less common.

The vast majority of trials in "University of Hawaii Cancer Center" are 391 trials for "All" genders, 93 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are NaN active trials in "University of Hawaii Cancer Center". undefined are not yet recruiting, 49 are recruiting, 138 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 272 completed trials in University of Hawaii Cancer Center, 5 suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in University of Hawaii Cancer Center, 27 "Phase 1" clinical trials were conducted, 215 "Phase 2" clinical trials and 222 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 29 trials that are defined as “Not Applicable".